Searched for
ATENOLOL
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%- Pharma sector: Reasons to look at it beyond the tariff exemption. 7 pharma stocks with an upside potential of up to 43%
- Necessary pill for portfolio during volatility and Trump tariff wars: 8 pharma stocks with an upside potential of up to 48%
- Health body issues safety warning about commonly-used BP and heart medicinesBeta-blockers, used for irregular heartbeat and hypertension, can cause dangerously low potassium levels, known as hypokalaemia, according ...08 Jan, 2025, 03.39 PM IST
- A Trump tariff tantrum-proof sector? 8 stocks from pharma sector, where Democrats and Republicans are in agreement, with an upside potential of up to 34% in 1 yearWhen Donald Trump is back in the saddle, one thing is certain: Tariff wars. Yes, China will be the biggest target. But for all those who th...20 Dec, 2024, 11.03 AM IST
- As smog engulfs the street, essential pills for a healthy of portfolio: 5 pharma stocks with an upside potential of up to 39%Here’s a lesson from history: For a long-term investor, buying in a correcting market is mostly an opportunity. The operative part, of cour...20 Nov, 2024, 01.35 PM IST
- IPC issues alert on painkiller drug nimesulide over adverse reactionPharma standards body Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert over nimesulide, saying the pill can trigger ras...12 Apr, 2024, 01.02 AM IST
- Finally out of the woods? 4 small and midcap pharma stocks with an upside potential of up to 26%Pharma as a sector has been under pressure for a very long time. Some time USFDA issues, at other instances of pricing pressure in US marke...27 Jun, 2023, 01.00 PM IST
- Essential medicines list: Govt adds 34 new drugs, drops 26; all you need to knowSeveral anti-cancer drugs, antibiotics and vaccines will now become more affordable as they are among 34 new additions to the National List...13 Sep, 2022, 08.16 PM IST
- Unichem Lab shares rise over 12% after USFDA approval for hypertension drugShares of the drug firm gained 7.04 per cent to trade at Rs 164 on the BSE.25 Nov, 2019, 03.40 PM IST
- JB Chemicals & Pharma gets USFDA nod for hypertension tablets"The USFDA has approved the company's supplementary Abbreviated New Drug Application (ANDA) for Atenolol tablets USP 25mg, 50mg and 100 mg,...13 Dec, 2017, 01.05 PM IST
- Popular antacid samples fail quality tests, company claims they were counterfeitsThe Pantocid and Pantocid DSR tested by CDSCO were not manufactured by Sun Pharma, the official spokesperson for the Mumbai-based drug make...18 Oct, 2017, 12.25 AM IST
- Fifteen stocks in focus on Friday, 31 March 2017Larsen & Toubro (L&T) announced on Thursday that it has won new orders worth Rs 4,000 crore from the hydro carbon sector.31 Mar, 2017, 08.41 AM IST
- Branded heart, diabetes drugs much costlier than generic onesIn the diabetes drugs segment the average price of leading brands of some medicines is also higher between 10-3 times the MRP of generic dr...10 Mar, 2017, 04.50 PM IST
- Cadila Healthcare recalls blood pressure drug in the USThe recall of the 5,400 bottles has been voluntarily initiated by the company through its US based arm Zydus Pharmaceuticals USA Inc.17 Oct, 2014, 03.22 PM IST
- Bafna Pharma gets Ghana's approval for hypertension drugBafna Pharmaceuticals on Wednesday said it has received Ghana health regulator's approval to sell Atenolol tablets, used in the treatment o...10 Nov, 2010, 08.24 PM IST
- Variation in bulk, retail prices to nail pharmasDrug makers governments will soon face tough questions from the drug price regulator.20 Aug, 2007, 05.07 AM IST
- Ranbaxy to mkt hypertension drug in USThe company has got FDA approval to market atenolol tablets of strengths 25 mg, 50 mg, and 100 mg.02 Jan, 2007, 03.15 PM IST
- Generics market may lose value on margin cutThe proposed trade margin cut on generic drugs from October 2 is set to be applicable to 2,000 brands of specified strengths, and as a resu...29 Sep, 2006, 02.23 AM IST
- Only 33 drugs to stay under price controlIT will be a mixed bag for the pharma industry. Pharma multinationals and domestic drug majors are expected to gain enormously with the che...18 Dec, 2001, 02.09 AM IST
Load More
